Phospho-STAT1 expression as a potential biomarker for anti-PD-1/anti-PD-L1 immunotherapy for breast cancer

In the present study, we evaluated the mechanisms of programmed death ligand 1 (PD-L1) expression in the breast cancer microenvironment, focusing on the role of interferon-γ (IFN-γ), and the clinical indications for anti-programmed cell death 1 (PD-1) /anti-PD-L1 immunotherapy. We evaluated PD-L1 ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakayama, Yuko, Mimura, Kosaku, Tamaki, Tomoaki, Shiraishi, Kensuke, Kua, Ley-Fang, Koh, Vivien, Ohmori, Masato, Kimura, Ayako, Inoue, Shingo, Okayama, Hirokazu, Suzuki, Yoshiyuki, Nakazawa, Tadao, Ichikawa, Daisuke, Kono, Koji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521934/
https://www.ncbi.nlm.nih.gov/pubmed/31081058
http://dx.doi.org/10.3892/ijo.2019.4779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521934/
https://www.ncbi.nlm.nih.gov/pubmed/31081058
http://dx.doi.org/10.3892/ijo.2019.4779

Ejemplares similares